Genetically modified HLA class I molecules able to inhibit human NK cells without provoking alloreactive CD8+ CTLs

Journal of Immunology

Volumn 168, Issue 7, 2002, Pages 3266-3274

  Sharland, Alexandra ^a   Patel, Amy ^a   Lee, Josie Han ^a   Cestra, Aimee E ^a   Saidman, Susan ^a   Waneck, Gerald L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; HLA ANTIGEN CLASS 1; HLA C ANTIGEN; LIGAND; PEPTIDE;

ALLOGENIC BONE MARROW TRANSPLANTATION; ALLOIMMUNITY; ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; GENE MUTATION; GENETIC TRANSFECTION; GRAFT REJECTION; HUMAN; HUMAN CELL; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECIPIENT; SWINE; XENOGRAFT;

EID: 0036533554     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.7.3266     Document Type: Article

References (99)

1. Xenogeneic transplantation
2. The pig as a potential xenograft donor
3. Xenogeneic human anti-pig cytotoxicity mediated by activated natural killer cells
4. Circulating human mononuclear cells exhibit augmented lysis of pig endothelium after activation with interleukin 2
5. Human NK cell-mediated direct and IgG-dependent cytotoxicity against xenogeneic porcine endothelial cells
6. Human NK cell and ADCC reactivity against xenogeneic porcine target cells including fetal porcine islet cells
7. Delayed xenograft rejection
8. Xenotransplantation: Recent progress and current perspectives
9. Both γδ T cells and NK cells inhibit the engraftment of xenogeneic rat bone marrow cells and the induction of xenograft tolerance in mice
10. Natural killer cells and their role in graft rejection
11. Immunobiology of natural killer cells and bone marrow transplantation: Merging of basic and preclinical studies
12. Natural killer cells in xenotransplantation
13. In search of the "missing self": MHC molecules and NK cell recognition
14. Biology of natural killer cells
15. Major histocompatibility complex class I antigens and the control of viral infections by natural killer cells
16. Natural killer cells
17. Immune inhibitory receptors
18. Inhibitory and activating receptors involved in immune surveillance by human NK and myeloid cells
19. NK cell recognition of non-classical HLA class I molecules
20. Human natural killer cell receptors and co-receptors
21. The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18
22. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells
23. Functional characterization of HLA-F and binding of HLA-F tetramers to ILT2 and ILT4 receptors
24. Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158)
25. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
26. New nomenclature for MHC receptors
27. Analysis of polymorphism in porcine MHC class I genes: Alterations in signals recognized by human cytotoxic lymphocytes
28. HLA-Cw3 expression on porcine endothelial cells protects against xenogeneic cytotoxicity mediated by a subset of human NK cells
29. Porcine aortic endothelial cells transfected with HLA-G are partially protected from xenogeneic human NK cytotoxicity
30. HLA-E and HLA-G expression on porcine endothelial cells inhibit xenoreactive human NK cells through CD94/NKG2-dependent and -independent pathways
31. HLA-G expression protects porcine endothelial cells against natural killer cell-mediated xenogeneic cytotoxicity
32. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors
33. Mixed chimerism as an approach to transplantation tolerance
34. Mixed chimerism and transplantation tolerance
35. Porcine aortic endothelial cells activate human T cells: Direct presentation of MHC antigens and costimulation by ligands for human CD2 and CD28
36. Evidence that activation of human T cells by porcine endothelium involves direct recognition of porcine SLA and costimulation by porcine ligands for LFA-1 and CD2
37. Human anti-pig T cell-mediated cytotoxicity
38. + cytolytic T cell clones
39. Human anti-porcine T cell response: Blocking with anti-class I antibody leads to hyporesponsiveness and a switch in cytokine production
40. Allele-specific and peptide-dependent recognition of swine leukocyte antigen class I by human cytotoxic T-cell clones
41. Demonstration of direct xenorecognition of porcine cells by human cytotoxic T lymphocytes
42. Characteristics of direct and indirect activation of human T cells against allogeneic and porcine xenogeneic cells/peptides
43. The human antiporcine cellular repertoire: In vitro studies of acquired and innate cellular responsiveness
44. Human natural killer cells account for non-MHC class I-restricted cytolysis of porcine cells
45. 2m double transgenic mice
46. Cytotoxic T cell responses in HLA-A2.1 transgenic mice: Recognition of HLA alloantigens and utilization of HLA-A2.1 as a restriction element
47. 3 domain into HLA B27
48. 3 domain of MHC I molecules
49. Selecting T cell receptors with high affinity for self-MHC by decreasing the contribution of CD8
50. + T cells are necessary for recognition of allelic, but not locus-mismatched or xeno-, HLA class I transplantation antigens
51. The molecular basis of allorecognition
52. Human minor histocompatibility antigens
53. The alloresponse
54. Surface structures involved in target recognition by human cytotoxic T lymphocytes
55. Monoclonal anti-Lyt-2 antibodies block the activation of cytolytic T lymphocyte precursors
56. T cell subsets and the recognition of MHC class
57. Transfection of the CD8 gene enhances T-cell recognition
58. Role of CD4 and CD8 in enhancing T-cell responses to antigen
59. + effector T cells recognize products of different major histocompatibility complex regions
60. 3 domain of class I influence the magnitude of the xenogeneic response
61. 3 domain of major histocompatibility complex class I molecules plays a critical role in cytotoxic T lymphocyte stimulation
62. Substitution at residue 227 of H-2 class I molecules abrogates recognition by CD8-dependent, but not CD8-independent, cytotoxic T lymphocytes
63. 3 domain: CD8 and the T-cell receptor recognize the same class I molecule
64. 3 domain of HLA-A2
65. Different effects of substitutions at residues 224 and 228 of MHC class I on the recognition of CD8
66. 3 domains of MHC class I
67. The binding site of NK receptors on HLA-C molecules
68. Crystal structure of the complex between human CD8αα and HLA-A2
69. Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand
70. 3 domain of HLA class I is critical to the differentiation of human cytotoxic T-lymphocytes specific for HLA-A2 and HLA-Cw4
71. Production of human cells expressing individual transferred HLA-A,-B,-C genes using an HLA-A,-B,-C null human cell line
72. Complete nucleotide sequence of a gene encoding a functional human class I histocompatibility antigen (HLA-CW3)
73. Correction of the HLA-Cw3 genomic sequence tentatively identifies it as HLA-Cw*0304
74. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells
75. Costimulatory signals are required for optimal proliferation of human NK cells
76. The HLA polymorphism of two distinctive South American Indian tribes: The Kaingang and the Guarani
77. Monoclonal antibodies: Purification, fragmentation and application to structural and functional studies of class I MHC antigens
78. Isolation and expression of a cDNA clone encoding HLA-Cw6: Unique characteristics of HLA-C encoded gene products
79. An estimation of the frequency of precursor cells which generate cytotoxic lymphocytes
80. Optimising a limiting dilution culture system for quantitating frequencies of alloreactive cytotoxic T-lymphocyte precursors
81. Characterization of recombinant human IL-2 with micromethods
82. Cloning human natural killer cells
83. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences
84. + T lymphocytes
85. Evidence of noninvolvement of swine class II in the in vitro proliferative response of human lymphocytes to porcine endothelial cells
86. Human T lymphocyte proliferative response to resting porcine endothelial cells results from an HLA-restricted, IL-10-sensitive, indirect presentation pathway but also depends on endothelial-specific costimulatory factors
87. TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide
88. Human leukocyte antigen F (HLA-F): An expressed HLA gene composed of a class I coding sequence linked to a novel transcribed repetitive element
89. The human class I MHC gene HLA-F is expressed in lymphocytes
90. b protein with a restricted expression pattern
91. T lymphocyte cloning from rejected human kidney allograft: Recognition repertoire of alloreactive T cell clones
92. Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors
93. The effect of HLA-C matching on acute renal transplant rejection
94. A correlation between HLA-C matching and donor antirecipient CTL precursor frequency in bone marrow transplantation
95. 3 domain mutants of MHC class I/peptide complex
96. Prospects for xenotransplantation
97. Coagulation and thrombotic disorders associated with pig organ and hematopoietic cell transplantation in nonhuman primates
98. Renal xenografts from triple-transgenic pigs are not hyperacutely rejected but cause coagulopathy in non-immunosuppressed baboons